Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer.
Reham HelwaLiv B GansmoMerete BjørnslettMari Kyllesø HalleHenrica M J WernerPål RomundstadKristian HveemLars VattenAnne DørumPer E LønningStian KnappskogPublished in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2021)
MDM2 SNP55T-allele may correlate with reduced risk for endometrial cancer in a SNP309T-, but not SNP309G, context.